The bone cancer groups that are sensitive and insensitive to SET KD–induced Bmi-1 degradation showed no correlation regarding Bmi-1, SET, PP2A, and Akt phosphorylation levels (Fig. S6, A and B). The gene discussed is BMI1; the disease is bone cancer.